193. Prader-Willi syndrome
95 clinical trials,   104 drugs   (DrugBank: 27 drugs),   50 drug target genes,   63 drug target pathways
Searched query = "Prader-Willi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02810483 (ClinicalTrials.gov) | December 2012 | 17/5/2016 | Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks | Randomized, Placebo Controlled Double-blind Study of the Efficacy of Topiramate on the Symptoms of Irritability - Impulsivity, Overeating and Self-harm in a Population of Patients Suffering From Prader Willi Syndrome Over 8 Weeks | Prader-Willi Syndrome | Drug: Topiramate;Drug: Placebo Comparator | Assistance Publique - Hôpitaux de Paris | NULL | Terminated | 12 Years | 45 Years | All | 69 | Phase 3 | France |
2 | NCT00065923 (ClinicalTrials.gov) | July 2002 | 1/8/2003 | Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome | Topiramate Effects on SIB in Prader-Willi Syndrome | Prader-Willi Syndrome;Self-Injurious Behavior | Drug: Topiramate | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | NULL | Completed | 18 Years | 66 Years | Both | 10 | N/A | United States |